title: When it comes to new drugs, if providers and payers snooze, they lose.
authors.forename: Linda
authors.initials: L
authors.lastname: Cahn
mesh_terms: D017046:Cost Savings; D003920:Diabetes Mellitus / Q000188:drug therapy; D017277:Drug Approval; D006264:Health Benefit Plans, Employee / Q000191:economics*; D006282:Health Personnel / Q000191:economics*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D055553:Prescription Drugs / Q000191:economics*; D014481:United States
chemical_list: D055553:Prescription Drugs